Prevalence of high-risk human papillomavirus and cervical lesion risk factors: A population-based study in Zhejiang, China 2010-2019

被引:6
|
作者
Lu, Wei [1 ]
Chen, Tingting [1 ]
Yao, Yimin [1 ]
Chen, Ping [1 ]
机构
[1] Zhejiang Chinese Med Univ, Affiliated Hosp 1, Clin Lab, 54 Youdian Rd, Hangzhou 310006, Zhejiang, Peoples R China
关键词
cervical cancer; human papillomavirus; p16; precancerous lesion; INTRAEPITHELIAL NEOPLASIA; HPV INFECTION; UTERINE CERVIX; E-CADHERIN; CANCER; EXPRESSION; P16(INK4A); CARCINOMA; GENOTYPES;
D O I
10.1002/jmv.27034
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
This study investigates the epidemiological characteristics of high-risk human papillomavirus (hrHPV) and analyzes the risk of cervical lesions among women in Zhejiang province, China. HPV data were collected retrospectively from a cohort of 67 742 women who underwent routine cervical cancer screening from 2010 to 2019. Precancerous and cervical cancer cases (n = 980) were histologically diagnosed as a low-grade squamous intraepithelial lesion (LSIL; n = 341) or a high-grade squamous intraepithelial lesion (HSIL; n = 499) and invasive cervical cancer (ICC) (n = 140) groups. Disordered logistic regression analysis was used to test the relationship between different degrees of cervical lesions, HPV16/18 infection status, positive rate of p16(INK4a) (p16), Ki-67 expression, and patient's age in SIL and ICC (270/980 cases) patients. HPV52 (4.7%) was the most prevalent HPV type, followed by HPV16 (3.3%) and HPV58 (2.6%). HPV16 was the most common HPV in SIL, peaking at the age of 30-39. The HPV16 infection rate was significantly higher in HSIL than in LSIL patients; moreover, HPV16, HPV18, and HPV51 infection rates were significantly higher in ICC patients than in HSIL (Bonferroni-adjusted p < 0.0167). The presence of HPV16/18 was also associated with a higher risk of developing HSIL from LSIL (odds ratio [OR] = 9.198, 95% confidence interval [CI]: 2.76-127.49). The increased p16 expression and HPV16/18 were associated with the increased risk of cancer progression (OR = 1.092, 95% CI: 1.03-1.36; OR = 1.495, 95% CI: 1.23-2.19, respectively). The identified hrHPV genotypes in cervical lesions can serve as a baseline indicator for future vaccine assessment in Zhejiang, China.
引用
收藏
页码:5118 / 5125
页数:8
相关论文
共 50 条
  • [41] Understanding the high-risk human papillomavirus prevalence and associated factors in the European country with a high incidence of cervical cancer
    Berza, Natalija
    Zodzika, Jana
    Kivite-Urtane, Anda
    Baltzer, Nicholas
    Curkste, Alise
    Pole, Ilva
    Nygard, Mari
    Parna, Kersti
    Stankunas, Mindaugas
    Tisler, Anna
    Uuskula, Anneli
    EUROPEAN JOURNAL OF PUBLIC HEALTH, 2024, 34 (04):
  • [42] Real-world effectiveness of primary screening with high-risk human papillomavirus testing in the cervical cancer screening programme in China: a nationwide, population-based study
    Zhao, Yanxia
    Bao, Heling
    Ma, Lan
    Song, Bo
    Di, Jiangli
    Wang, Linhong
    Gao, Yanqiu
    Ren, Wenhui
    Wang, Shi
    Wang, Hai-Jun
    Wu, Jiuling
    BMC MEDICINE, 2021, 19 (01)
  • [43] Real-world effectiveness of primary screening with high-risk human papillomavirus testing in the cervical cancer screening programme in China: a nationwide, population-based study
    Yanxia Zhao
    Heling Bao
    Lan Ma
    Bo Song
    Jiangli Di
    Linhong Wang
    Yanqiu Gao
    Wenhui Ren
    Shi Wang
    Hai-Jun Wang
    Jiuling Wu
    BMC Medicine, 19
  • [44] Use of a high-risk human papillomavirus DNA test as the primary test in a cervical cancer screening programme: a population-based cohort study
    Zorzi, M.
    Del Mistro, A.
    Farruggio, A.
    de' Bartolomeis, L.
    Frayle-Salamanca, H.
    Baboci, L.
    Bertazzo, A.
    Cocco, P.
    Fedato, C.
    Gennaro, M.
    Marchi, N.
    Penon, M. G.
    Cogo, C.
    Ferro, A.
    BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2013, 120 (10) : 1260 - 1268
  • [45] High-risk Human Papillomavirus in a screening population
    Schledermann, D. E.
    Rasmussen, M.
    Mose, L.
    APMIS, 2011, 119 : 18 - 19
  • [46] Prevalence of High-Risk Human Papillomavirus Infections before and after Cervical Lesion Treatment, among Women Living with HIV
    Dub, Timothee
    Le Coeur, Sophie
    Ngo-Giang-Huong, Nicole
    Matanasarawut, Wanmanee
    Suriyachai, Pornnapa
    Saisawat, Kannikar
    Putiyanun, Chaiwat
    Buranabanjasatean, Sudanee
    Leenasirimakul, Prattana
    Randaeng, Samreung
    Delory, Tristan
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (14)
  • [47] Changes in High-Risk HPV Infection Prevalence and Associated Factors in Selected Rural Areas of China: A Multicenter Population-Based Study
    Yu, Yan-Qin
    Jiang, Ming-Yue
    Dang, Le
    Feng, Rui-Mei
    Bangura, Mohamed S.
    Chen, Wen
    Qiao, You-Lin
    FRONTIERS IN MEDICINE, 2022, 9
  • [48] Hospital-based prevalence and sensitivity of high-risk human papillomavirus in Thai urban population
    Suwannarurk, Komsun
    Tapanadechopol, Pairath
    Pattaraarchachai, Junya
    Bhamarapravati, Sutatip
    CANCER EPIDEMIOLOGY, 2009, 33 (01) : 56 - 60
  • [49] Population-based Case-control Study on Risk Factors for Esophageal Cancer in Five High-risk Areas in China
    Sun, Xibin
    Chen, Wanqing
    Chen, Zhifeng
    Wen, Denggui
    Zhao, Deli
    He, Yutong
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2010, 11 (06) : 1631 - 1636
  • [50] Human papillomavirus prevalence and associated factors in women and men in south China: a population-based study
    Wei, Feixue
    Yin, Kai
    Wu, Xin
    Lan, Jian
    Huang, Shoujie
    Sheng, Wei
    Zhao, Jun
    Su, Yingying
    Wang, Ying
    Li, Yanping
    Li, Rongcheng
    Zhang, Jun
    Li, Mingqiang
    Wu, Ting
    Xia, Ningshao
    EMERGING MICROBES & INFECTIONS, 2016, 5 : 1 - 8